MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration

PURPOSE: Currently, no outcome measures are clinically validated and accepted as clinical endpoints by regulatory agencies for drug development in intermediate age-related macular degeneration (iAMD). The MACUSTAR Consortium, a public-private research group funded by the European Innovative Medicine...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ophthalmologica
Prif Awduron: Finger, Robert P., Schmitz-Valckenberg, Steffen, Schmid, Matthias, Rubin, Gary S., Dunbar, Hannah, Tufail, Adnan, Crabb, David P., Binns, Alison, Sánchez, Clara I., Margaron, Philippe, Normand, Guillaume, Durbin, Mary K., Luhmann, Ulrich F.O., Zamiri, Parisa, Cunha-Vaz, José, Asmus, Friedrich, Holz, Frank G.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: S. Karger AG 2019
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482983/
https://ncbi.nlm.nih.gov/pubmed/30153664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000491402
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg